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Abstract
Aerobic fitness, measured as maximal oxygen uptake (VO2max), is a good indicator of cardiovascular health, and a strong
predictor of cardiovascular mortality. Biomarkers associated with low VO2max may therefore represent potential early
markers of future cardiovascular disease (CVD). The aim of this study was to assess whether circulating microRNAs (miRs) are
associated with VO2max-level in healthy individuals. In a screening study, 720 miRs were measured in serum samples from
healthy individuals (40–45 yrs) with high (n = 12) or low (n = 12) VO2max matched for gender, age and physical activity.
Candiate miRs were validated in a second cohort of subjects with high (n = 38) or low (n = 38) VO2max. miR-210 and miR-222
were found to be higher in the low VO2max-group (p,0.05). In addition, miR-21 was increased in male participants with low
VO2max (p,0.05). There were no correlations between traditional risk factors for CVD (blood pressure, cholesterol, smoking
habit, or obesity) and miR-21, miR-210 and miR-222. DIANA-mirPath identified 611 potential gene-targets of miR-21, miR-
210 and miR-222, and pathway analysis indicated alterations in several important signaling systems in subjects with low
VO2max. Potential bias involve that blood was collected from non-fasting individuals, and that 8 performed exercise within
24 h before sampling. In conclusion, we found that miR-210, miR-21, and miR-222 were increased in healthy subjects with
low VO2max. The lack of association between these three miRs, and other fitness related variables as well as traditional CVD
risk factors, suggests that these miRs may have a potential as new independent biomarkers of fitness level and future CVD.
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Introduction
Aerobic fitness measured as maximal oxygen uptake (VO2max) is
a good indicator of cardiovascular health, and a strong predictor of
cardiovascular mortality in healthy individuals and in patients with
cardiovascular disease (CVD) [1–4]. CVD is currently the
predominant cause of morbidity and mortality in developed
countries. To manage this pandemic, new and effective prevention
strategies as well as new biomarkers of CVD risk are needed [5].
Based on the strong association between low aerobic fitness and
CVD mortality, biomarkers associated with aerobic fitness may
thus represent potential early markers of CVD.
Recently, microRNAs (miRs) have emerged as promising
biomarkers of disease, as large amounts of stable miRs can enter
the circulation [6]. miRs are short, endogenous, single-stranded,
noncoding RNAs that negatively regulate gene expression [7].
More than 1000 miRs have so far been discovered, and their
dysregulation have been associated with different pathologies like
cancer and CVD [8–10]. Previously, increased circulating levels of
miR-1 have been associated with myocardial infarction [11],
circulating levels of miR-423 have been associated with heart
failure [12], and circulating levels of miR-208 have been
associated with myocardial damage in CVD [13–15]. Recently,
several papers also report that circulating miRs may serve
important endocrine functions in health and disease [16,17].
To our knowledge, there are no previous studies reporting
differences in circulating miRs in proportion to aerobic fitness
level. As low aerobic fitness is an important risk factor of CVD,
miRs that are upregulated in subjects with low aerobic fitness may
represent early biomarkers of CVD. The aim of this study is to use
new methods of miR-profiling to identify novel biomarkers
associated with high and low VO2max.
Methods
Ethics Statement
The study is in conformity with Norwegian laws and the
Helsinki declaration, and all participants signed a document of
informed consent. The study was approved by the Regional
Committees for Medical and Health Research Ethics (REC
Central).
Subjects
The third wave of the Nord-Trøndelag Health Study (HUNT3
Study) in Norway was carried out between 2006 and 2008.
Participants in the present study attended a sub-study in HUNT3
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designed to measure maximal oxygen uptake (VO2max) in healthy
adult subjects and was called the HUNT Fitness Study [18].
Participants in the Fitness Study reported to be free from heart- or
lung disease (details previously described [18]). Other exclusion
criteria were cancer, pregnancy, or any other medical contrain-
dication or orthopaedic limitation not permitting a maximal
exercise stress test.
From the eligible 4631 participants who had completed
a successful VO2max-test in the HUNT Fitness Study, 12
participants with high VO2max and 12 participants with low
VO2max were selected for the initial screening study. All subjects
were between 40 and 45 years old and were matched on gender,
age (within 0.9 year between case and control), and equal levels of
physical activity. In addition, the subjects were matched on the
basis of having as similar as possible body mass index (BMI), blood
pressure (BP), and serum levels of glucose, cholesterol and
triglycerides. Thus, the only cardiovascular risk factor that was
different between the cases and the controls was VO2max.
To verify the findings in a validation cohort, 76 new participants
from the HUNT Fitness Study were selected (38 with low VO2max
and 38 with high VO2max) based on the same matching criterias as
for the screening cohort.
Anthropometric Measurements
Weight and height were measured on a combined scale DS-102
(Arctic Heating AS, Nøtterøy, Norway), and BMI was calculated
as weight divided by height squared (kg/m2). An individualized
protocol was applied to measure VO2max [19]. Oxygen uptake
kinetics were measured directly by a portable mixing chamber gas-
analyzer (Cortex MetaMax II, Cortex, Germany) with the
participants wearing a tight face mask (Hans Rudolph, Germany)
connected to the MetaMax II. The system has formerly been
found to be valid [20]. Heart rate was measured by radio telemetry
(Polar S610i, Polar Electro Oy, Finland). From the warm-up pace,
the load was regularly increased when oxygen uptake kinetics
flattened. Along with a respiratory quotient of 1.05 or higher,
a maximal test was considered achieved when the oxygen uptake
did not increase more than 2 ml/kg/min at the highest effort or
before the participant disembarked the treadmill [21]. VO2max
was measured as litres of oxygen per minute (l/min) and
subsequently calculated as VO2max relative to body mass (ml/
kg/min) and VO2max scaled (ml/kg
0.75/min).
Blood Sampling and Standard Biochemical Analyses
Blood sampling was performed before the start of the exercise
test. Standard biochemical analyses were performed on fresh
venous non-fasting blood samples at Levanger Hospital, Norway.
Non-fasting glucose was analysed by Hexokinase/G-G-PDH
methodology reagent kit 3L82-20/3L82-40 Glucose, high-density
lipoprotein (HDL) cholesterol by the Accelerator selective de-
tergent methodology reagent kit 3K33-20 Ultra HDL, triglycer-
ides by Glycerol Phosphate Oxidase methodology reagent kit
7D74 Triglyceride, alanine aminotransferase (ALAT) by NADH
(with P-59-P) methodology reagent kit 8D36-30 Alanine amino-
transferase activated, aspartate aminotransferase (ASAT) by
NADH (with P-59-P) methodology reagent kit 8D37-30 Aspartate
aminotransferase activated, and C-reactive protein (CRP) was
analysed by the Areoset CRP Vario kit (all analyses from Abbott
Diagnostics, Illinois, US). ALAT measurements below the de-
tection limit (LoD) were assigned a concentration of 9 u/l, ASAT
measurements below LoD a concentration of 7 u/l, and CRP
levels below LoD were recorded as 0 mg/l.
Questionnaire-based Information
Physical activity was registered based on the responses to a self-
administered questionnaire [22]. The questionnaires included
three questions: Question 1: ‘‘How frequently do you exercise?’’,
with the response options ‘‘Never’’ (0), ‘‘Less than once a week’’
(0.5), ‘‘Once a week’’ (1), ‘‘2–3 times per week’’ (2.5) and ‘‘Almost
every day’’ (5). Question 2: ‘‘If you exercise as frequently as once
or more times a week: How hard do you push yourself?’’ with the
response options: ‘‘I take it easy without breaking a sweat or losing
my breath’’ (1), ‘‘I push myself so hard that I lose my breath and
break into sweat’’ (2) and ‘‘I push myself to near exhaustion’’ (3).
Question 3: ‘‘How long does each session last?’’, with the response
options: ‘‘Less than 15 minutes’’ (0.1), ‘‘16–30 minutes’’ (0.38), ‘‘30
minutes to 1 hour’’ (0.75) and ‘‘More than 1 hour’’ (1.0). Each
participant’s response to the above three questions (i.e. numbers in
parentheses) were multiplied to calculate a physical activity index
score (Kurtze score). As the second and third question only
addressed people who exercised at least once a week, both
‘‘Never’’ and ‘‘Less than once a week’’ yielded an index score of
zero. Participants with a zero score were categorized as inactive.
The Finnish Type 2 Diabetes Risk Score (FINDRISC) was
calculated for all the participants based on lifestyle variables,
family history and BMI. FINDRISC predicts the risk of being
diagnosed with type 2 diabetes in the next ten years and requires
no laboratory measurements [23]. We also calculated the
Framingham Risk Score, which estimates the 10-year risk of
having a myocardial infarction, and the NORRISK Score, which
is optimized for the Norwegian population and estimates the 10-
year risk of cardiovascular mortality [24,25].
miR Isolation
miRs were extracted from serum using the miRNeasyH Mini
Kit (Qiagen, US). To control isolation efficiency, two syntetic
spike-ins were added to the samples (UniSp2 and UniSp4). Briefly,
750 ml of a Qiazol mixture containing 1.25 mg/ml of MS2
bacteriophage RNA (RNA carrier not containing miRs) was added
to 200 ml serum. The MS2 bacteriophage was added to increase
the extraction of miRs. miRs were then extractet using chloro-
form, ethanol and spin columns. miRs were eluted in 50 ml of
RNase-free water and stored in a 280uC freezer prior to analysis.
Real-time Quantitative Polymerase Chain Reaction (RT-
qPCR)
Fifteen ml RNA was reversely transcribed in 75ml reactions using
the miRCURY LNATM Universal RT microRNA PCR, Poly-
adenylation and cDNA synthesis kit (Exiqon, Denmark). cDNA
was diluted 506and assayed in 10 ml PCR reactions according to
the protocol for miRCURY LNATM Universal RT microRNA
PCR. For the screening approach, all miRs were assayed once by
RT-qPCR on the microRNA Ready-to-Use PCR, Human panel I
and panel II. For the validation approach, selected candidate miR
were analysed by the custom-made ‘‘Pick-and-mix’’ RT-qPCR
system (Exiqon, Denmark). Negative controls excluding template
from the reverse transcription reaction was included and profiled
like the samples. The amplification was performed in a Light-
CyclerH 480 RT-qPCR System (Roche, Switzerland) in 384 well
plates. The amplification curves were analysed using the Roche
LC software, both for determination of Cp (by the 2nd derivative
method) and for melting curve analysis.
miR Data Analysis
Screening of 720 miRs was performed in serum samples and the
amplification efficiency was calculated using algorithms similar to
MicroRNAs and Aerobic Fitness
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the LinReg software. All assays were inspected for distinct melting
curves and the Tm was checked to be within known specifications
of the assay. Individual miRs had to be detected with Cp,37 and
5 Cp’s less than the negative control (blank) to be included in the
data analysis. Data that did not pass these criteria were omitted
from further analysis. Using SLqPCR on the screening cohort, the
best normalizer was found to be the average of assays detected in
all samples (global mean) and therefore data were normalized to
the global mean (average – assay Cp). For the validation cohort,
we normalized data to the level of miR-425, as miR-425 levels
were expressed close to the global mean in the screening cohort
and miR-425 previously has been found valid as a housekeeping
miR [26].
miR Target Prediction
The web-based computational tool DIANA-mirPath was used
to identify molecular pathways potentially altered by the co-
ordinated change in expression of the three fitness-miRs [27].
DIANA mirPath combines the prediction tool Targetscan 5.1 and
the pathway tool KEGG (Kyoto Encyclopedia of Genes and
Genomes). DIANA-mirPath was set to use TargetScan Human 5.1
to identify possible mRNA targets. The level of significance was set
at p,0.05.
Statistical Analysis
PASW Statistics 17.0 (IBM, US) was used for traditional
statistical analyses. All statistical tests were two-sided, and p-values
below 0.05 were considered statistically significant. Kolmogorov-
Smirnov test was used to test for normality. One-Way ANOVA
was used to compare variables between the high and the low
VO2max groups. Pearson’s correlation was used to study associa-
tions between normally distributed variables. Linear regression
analysis was used to predict the contribution of miRs to the level of
VO2max. Logistic regression was uset to determine the odds ratios
for different predictors and outcomes.
Results
The baseline characteristics of the populations are displayed in
the Table 1. Out of the 720 analyzed miRs, 50 miRs were
successfully assessed with sufficient signal in .80% of the samples
and qualified for further analyses. Participants with low VO2max
had significantly higher levels of miR-210 and miR-125a
compared to participants with high VO2max in the screening
cohort (ddCp.+/20.50, p,0.01) (Figure 1A). In addition,
subjects with low VO2max had significantly lower serum levels of
miR-652 (p,0.001) (Figure 1A). In male participants, low VO2max
was associated with reduced levels of miR-151 and increased levels
of miR-29a and miR-125a compared to male participants with
high VO2max (Figure 1B). In women, miR-210, let-7d and miR-21
were increased in subjects with low VO2max compared to subjects
with high VO2max (ddCp.+/20.50 and p,0.05) (Figure 1C).
Based on the screening approach, the 7 significant miRs (miR-
210, miR-21, miR-125a, miR-652, miR-151, miR-29a, and let-7d)
were selected for further testing in the validation cohort. We also
included miR-222 based on the significant correlation with self-
reported habitual exercise intensity (r = 0.5, p,0.05). Additionally,
three miRs that were stable expressed in the screening cohort
(miR-16, miR-103, miR-425) were also included in the validation
cohort for the purpose of endogenous normalization.
In the validation cohort, the level of circulating miR-210 and
miR-222 were 30% and 20% higher, respectively in participants
with low VO2max compared to participants with high VO2max
(p,0.05) (Figure 2A). In addition, the miR-21 levels were 20%
higher in male participants with low VO2max compared to male
participants with high VO2max (p,0.05) (Figure 2B). The miR-
125a levels were below the detection limit in most of the samples in
the validation cohort and the group differences could therefore not
be evaluated.
We observed a significant positive correlation between miR-21
and miR-210 (r = 0.42, p,0.0005), between miR-222 and miR-21
(r = 0.74, p,0.0005), and between miR-210 and miR-222
(r = 0.35, p,0.005) in the validation cohort.
Correlations between miRs and Fitness Related Variables
A significant inverse correlation was found between VO2max
and miR-210 (n = 100, r =20.35, p,0.001). Despite the observed
group differences in miR-222 and miR-21, only a weak correlation
was found between miR-21 and VO2max (n = 100, r =20.20,
p,0.05) and no correlation was found between miR-222 and
VO2max. No correlations were found between miR-210, miR-21
and miR-222 and exercise habits like frequency, intensity, and
duration of self-reported regular physical activity, nor with self-
reported time since last bout of exercise in the validation cohort.
Linear regression analysis showed that the serum level of miR-
210 explained 12% of the variation in VO2max (r
2 = 0.12). When
adding the serum levels of miR-21 and miR-222 to the analysis,
these three miRs in combination explained 15% of the variation in
VO2max. However, the best prediction model for VO2max was
obtained by using miR-210 alone. miR-210 levels in the lowest
quartile increased the odds ratio by 10.4 times for having a high
VO2max (.120 ml/kg
0.75/min).
Correlations between miRs and Variables Related to CVD
Risk
We observed significant correlations between the FINDRISC
Score and miR-21 (n = 100, r = 0.37, p,0.001) and miR-222
(n = 100, r = 0.34, p,0.001). Assessing correlations with other
CVD risk factors, we found a positive correlation between miR-21
and CRP (n = 51, r = 0.35, p,0.05) and between miR-210 and
serum ASAT (n = 16, r = 0.78, p,0.0005). let-7d (n = 34 r = 0.48,
p,0.005), and miR-103 (n = 62 r = 0.31, p,0.05), were also
positively correlated with age in the validation cohort. In contrast,
we found no correlations between the most common risk factors
for CVD (BP, cholesterol, smoking habit, or obesity) and miR-21,
miR-210 and miR-222 levels. Moreover, no correlations were
found between the Framingham Risk Score or the NORRISK
Score and miR-21, miR-210 and miR-222 levels.
Targeted Pathways by Fitness-miRs
Bioinformatics may provide insight into signaling pathways that
are targeted by different miRs [27]. Using bioinformatics, miR-21,
miR-210 and miR-222 were predicted to target 611 genes. The
KEGG pathway database recognized 138 of those genes. The
signaling pathways that, based on prediction, were found to
significantly segregate subjects with high and low VO2max were the
MAPK pathway, TGF-b pathway, B-cell receptor pathway, Wnt
pathway, T-cell receptor pathway, mTOR pathway, p53 pathway,
ErbB pathway, and VEGF pathway (p,0.05).
Discussion
Despite the strong association between aerobic fitness level and
the risk of future cardiovascular mortality, only limited in-
formation is currently available on serum biomarkers associated
with aerobic fitness level. The present study demonstrates
a potential value of circulating miRs as fitness biomarkers in
a large cohort of healthy individuals. Our results especially identify
MicroRNAs and Aerobic Fitness
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Figure 1. MicroRNAs with significantly different serum levels in individuals with high and low aerobic fitness in the screening
cohort (p,0.05). A: In both men and women (n = 24), B: Men (n = 12), C: Women (n = 12). VO2max: Maximal oxygen uptake. Error bars represent 1
standard deviation.
doi:10.1371/journal.pone.0057496.g001
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miR-210 as a promising biomarker of aerobic fitness level based
on increment in the low VO2max group of both the screening and
validation cohort and the significant correlation with VO2max.
Several previous studies have shown that induction of miR-210
is a hallmark of insufficient oxygen supply to tissues (hypoxia) [28–
32]. The role of miR-210 during hypoxia is suggested to involve
repression of mitochondrial metabolism, which is considered an
important factor for aerobic fitness [33]. Tissue hypoxia plays
a central role in the pathogenesis of ischemic disorders, such as
myocardial infarction, stroke and peripheral artery disease [34]. A
hypoxia-induced expression of miR-210 has been reported in
several different organs, e.g. endothelium and the heart [29–31].
Furthermore, increased serum levels of miR-210 have been
reported in patients with atherosclerosis and kidney disease
[35,36]. Since our cohort consists of predominantly healthy
subjects, excluding subjects suffering from the most common
diseases, the high level of miR-210 in subjects with low aerobic
fitness may be an indication of hypoxic conditions, decreased
mitochondrial metabolism and potentially subclinical disease in
the cardiovascular system. Furthermore, since the high and low
VO2max group was similar regarding risk factors for CVD, miR-
210 may represent an early marker of CVD risk even beyond
traditional risk factors. The theory that miR-210 may provide
information beyond traditional risk factors is strengthened by the
lack of association with conventional cardiovascular risk scores.
In addition to miR-210, we also found significantly higher
circulating levels of miR-21 and miR-222 in subjects with low
aerobic fitness. miR-21 is one of the most highly and consistently
up-regulated miRs during pathological cardiac hypertrophy and
has received considerable attention as a marker of oxidative stress,
inflammation, and pathology in both cardiomyocytes and
endothelial cells [37–43]. In the present study, a significant
positive correlation was found between serum levels of miR-21 and
CRP, supporting the previous associations between miR-21 and
inflammation. Since miR-21 is a highly ubiquitous miRNA found
to be regulated by several conditions, we believe that this marker
has to be included as a panel of markers to be usuful in prediction
of fitness level and cardiovascular risk.
Less is known about circulating levels of miR-222, but strong
expressions has been reported in vascular smooth muscles after
vascular injury and in endothelial cells stimulated with angioge-
netic factors [44,45]. Furthermore, Baggish et al reported that
vascular endothelial cells are capable of releasing high levels of
both miR-21 and miR-222 in to the circulation [16].
The exact cellular sources of the measured miR-210, miR-21
and miR-222 in this study remains unclear and needs to be further
elucidated in animal models and human subjects. However,
a common denominator for these 3 miRs is the high expression in
endothelial cells (Table 2) [29,30,35,42,44–46]. Theoretially,
release of miR-210, miR-21 and miR-222 from the endothelium
in healthy subjects with low VO2max could be related to subclinical
artherosclerosis, hypoxia or inflammation, hence providing
a rationale for these miRs as novel early markers of CVD.
Furthermore, additional organs could contribute to the circulating
Table 1. Baseline characteristics of the study populations.
microRNA screening microRNA validation
Characteristics Low VO2max (n=12) High VO2max (n=12) Low VO2max (n=38) High VO2max (n=38)
Age 42.7 (1.6) 42.6 (1.7) 45.6 (3.2) 45.4 (3.3)
Gender (n = female/male) 6/6 6/6 19/19 19/19
VO2max (ml/kg
0.75/min) 104.2 (16.6) 151.2 (18.5) 101.1 (18.0) 145.2 (20.7)
Physical activity, Kurtze score [22] 3.5 (1.3) 3.5 (1.3) 3.8 (1.3) 3.8 (1.3)
Weight (kg) 72.6 (8.7) 80.2 (12.9) 78.1 (15.0) 79.5 (10.7)
Waist (cm) 87.8 (6.7) 89.0 (7.1) 90.4 (10.6) 89.6 (8.2)
Height (cm) 169.6 (6.2) 175.7 (10.6) 172.5 (10.1) 172.9 (7.7)
Hip (cm) 100.8 (4.9) 102.4 (6.6) 102.0 (7.1) 102.5 (5.8)
Body mass index (kg/m2) 25.2 (1.7) 25.8 (2.0) 26.1 (3.4) 26.6 (3.0)
Daily smoking (n) 1 1 4 2
Diabetes (n) 0 0 1 0
Systolic BP (mmHg) 126.8 (12.0) 123.3 (11.0) 125.5 (15.5) 128.1 (15.5)
Diastolic BP (mmHg) 69.3 (10.2) 72.9 (9.4) 75.9 (11.4) 74.3 (9.6)
Non-fasting glucose (mmol/l) 4.9 (1.1) 4.9 (0.8) 5.4 (1.3) 5.3 (1.1)
Non-fasting HDL-cholesterol (mmol/l) 1.3 (0.3) 1.3 (0.3) 1.3 (0.4) 1.4 (0.3)
Total cholesterol (mmol/l) 5.3 (1.0) 5.1 (0.8) 5.4 (1.3) 5.4 (0.9)
Serum triglycerides (mmol/l) 1.5 (0.5) 1.4 (0.7) 1.9 (1.3) 1.7 (1.0)
Serum CRP (mg/l) 0.7 (0.5) 0.9 (0.8) 2.3 (3.4) 0.9 (0.9)
Serum ALAT (u/l) n,3* n,3* 16.8 (5.3) 23.4 (12.7)
Serum ASAT (u/l) n,3* n,3* 22.5 (6.0) 21.6 (6.3)
FINDRISC Score 4.7 (3.1) 4.8 (2.3) 7.2 (3.5) 7.0 (3.6)
Values are presented as mean with standard deviation in bracles. Some of the values describe only the number of people having certain characteristics (gender, daily
smokers and diabetics). VO2max: Maximal oxygen uptake, BP: Blood pressure, HDL: High-density lipoprotein, CRP: C - reactive protein, ALAT: Alanine aminotransferase,
ASAT: Aspartate aminotransferase.
n,3*: Less than three subjects that had performed this test.
doi:10.1371/journal.pone.0057496.t001
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miR-210, miR-21 and miR-222 levels, including the heart.
Although the participants in this study had no clinical overt heart
disease, miR-210 and miR-21 have previously been found
upregulated in cardiac hypertrophy, which can also be found in
asymptomatic subjects [37,47].
Interestingly, a strong positive correlation was found between
circulating levels of miR-210 and serum levels of ASAT. ASAT is
commonly measured clinically as a marker of hepatocellular
damage, but can also be released from injured myocardium.
ASAT values are known to be influenced by exercise training and
may remain significantly increased for several days after a bout of
heavy exercise [48]. In our subjects the ASAT values were within
the normal range. However the close correlation to miR-210 may
indicate that the ASAT and miR-210 originates from the same
organ. Since the correlation between ASAT and miR-210 is based
on only 16 subjects, more research is needed to elucidate the
association.
Correlations between miRs and Variables Related to
Fitness and CVD Risk
In this study we have matched the contrasting groups on
physical activity level (based on the Kurtze score [22]), to avoid
finding typical exercise induced miRs. Previous studies have shown
that circulating levels of miR-21 and miR-222 are regulated by
acute and long-term exercise training [16]. However, circulating
levels of miR-210 have previously been reported to be unaffected
both by acute and long-term exercise training [16]. In our study,
no correlations were found between miR-210, miR-21 and miR-
222 and exercise habits like frequency, intensity, or duration of
self-reported regular exercise training. Additionally, no correla-
tions were found between the three miRs and the time since the
last exercise bout. Based on this, we can probably rule out the
possibility that acute effects of exercise are responsible for our
findings.
Figure 2. MicroRNAs with significant (or borderline significant) up-regulation in serum samples from subjects with low aerobic
fitness compared to subjects with high aerobic fitness. A: In both men and women (n = 76), B: Both gender analyzed separately (n = 38 men,
n = 38 women). VO2max: Maximal oxygen uptake. Error bars represent 1 standard deviation.
doi:10.1371/journal.pone.0057496.g002
MicroRNAs and Aerobic Fitness
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Surprisingly, no correlations were found between miR-21, miR-
210 and miR-222 levels and important CVD risk factors such as
BP, cholesterol, smoking habit, and obesity. However, miR-21 and
miR-222 correlated with the FINDRISC score, which predicts the
risk of being diagnosed with type 2-diabetes in the next ten years.
As mentioned above, this finding strengthens our hypothesis that
fitness biomarkers also have potential as markers of future
cardiovascular health independent of traditional biomarkers.
Target Genes and Pathways
miR-210 is considered the hypoxia-miR [28]. Thus, the high
circulating levels of miR-210 in subjects with low VO2max, may
suggest that hypoxia-induced pathways are activated. In line with
this, the mirPath prediction tool identified the VEGF pathway,
which is another important hypoxia pathway, to be differentially
activated in the high and low VO2max group. Interestingly, in
endothelial cells miR-210 and the VEGF pathway seem to interact
in the formation of new capillaries [30]. However, whether
subjects with low aerobic fitness have increased activity in hypoxia-
and angiogenesis pathways to compensate for the low oxygen
uptake, will need confirmation in additional clinical and experi-
mental studies.
The pathway analysis also predicted that miR-21, miR-210 and
miR-222 inhibit the expression of several key proteins in more
general pathways associated with growth and development
(MAPK, TGF-b, mTOR, ErbB and the Wnt pathways), the
immune system (T and B cell signaling) and stress (p53 pathway).
Potentially induced pathways in the vessel wall and the heart of
subjects with low VO2max are illustrated in Figure 3. The
implications of this for the pathophysiology of subjects with low
VO2max is not clear and will need more detailed studies of specific
Table 2. Tissue of expression, associated cardiovascular diseases and biological processes linked to the differentially expressed
microRNAs in this study.
miRs Tissue expression Cardiovascular diseases Biological processes
miR-210 Endothelium [29,30,35,46] Atherosclerosis [35,49] Angiogenesis [29]
Artherosclerotic plaque [49] Myocardial infarction [50] Hypoxia [28–33,46]
Heart [46,50] Proliferation [30]
Mitochondrial metabolism [33]
miR-222 Endothelium [44,45] Atherosclerosis [35] Angiogenesis [44]
Proliferation [45]
miR-21 Endothelium [42] Atherosclerosis [35,49] Cardiac hypertrophy [38,41]
Artherosclerotic plaque [49] Heart failure [41] Stress [42]
Heart [40,41] Inflammation [43]
Apoptosis [42]
miR: microRNA, VO2max: Maximal oxygen uptake.
doi:10.1371/journal.pone.0057496.t002
Figure 3. Potentially increased microRNAs and associated pathways in subjects with low maximal oxygen uptake (VO2max). The
connections between the biological processes, microRNAs and the regulated pathways in A) the vessel wall and (B) the heart are based on the
current knowledge in the literature. Red boxes illustrate the microRNAs that were increased in patients with low VO2max and the yellow boxes depict
the associated pathways as identified by miR-Path analyses. Upward arrows inside the boxes illustrate up-regulation and downward arrows illustrate
down-regulation. Blue dashed lines indicate the putative release of the microRNAs to the circulation. Pointed arrows illustrate activation and flat
arrows illustrate inhibition. c-miR: Circulating microRNA, VEGF: Vascular endothelial growth factor, VO2max: Maximal oxygen uptake.
doi:10.1371/journal.pone.0057496.g003
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pathways. We also acknowledge that currently only limited
information is available regarding the origin of circulating miRs.
Hence, extrapolating from miRs in the peripheral blood to
functional aspects in specific organs should be done with caution.
Still, the association to hypoxia- and angiogenesis-related path-
ways seems interesting and should be further explored.
To our knowledge only one previous study has described that
circulating miRs may be associated with fitness measured as
VO2max [16]. This paper has reported a positive correlation
between the circulating levels of miR-146a and VO2max [16]. No
such correlation was found in this study. However, this discrep-
ancy may be explained by the differences in study-population as
Baggish et al studied 10 male athletic subjects [16].
Limitations
One limitation of this study is that the analyzed blood samples
were collected from non-fasting individuals. However, the time
since last meal was similar in both the high and low VO2max group
(3.1 hours). We therefore believe that food intake did not influence
the miR results. Another limitation of the study is that 8 of the 100
participants reported to have performed exercise training the same
day as blood sampling, spanning from 1 hour to 11 hours before
the samples were collected. Baggish et al have previously shown
that exercise training ,24 hours before blood sampling can
influence the levels of circulating miRs such as miR-222 and miR-
21 independent of VO2max. However, removing these 8 partici-
pants from the statistical tests had no influence on the results.
Furthermore, correlation analysis between miR-levels (miR-21,
miR-210, miR-222) and self-reported time since last bout of
exercise showed no correlations.
Conclusion
The results from this study suggest a potential value of
measuring circulating miRNAs as biomarkers of aerobic fitness.
The results indicated that miR-210 was the best marker of
VO2max-level, based on increment in the low VO2max group in
both the screening and validation cohort, and the significant
correlation with VO2max-level. The lack of association between
miR-210, miR-21, miR-222, and other fitness related variables
indicates that these three miRs may have potential as new
independent biomarkers of fitness level. Furthermore, the lack of
association between miR-210, miR-21, miR-222 and traditional
CVD risk factors suggest a potential of these miRs as early
biomarkers of future cardiovascular health, and should be further
studied. Potential bias involve that blood samples were collected
from non-fasting individuals, and that 8 of the participants
reported to have performed exercise training within 24 hours
before sampling.
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